Topical JAK Inhibitor Shows Itch Relief in Prurigo Nodularis Trial
Patients treated with a topical JAK inhibitor experienced significant reductions in itch as early as day 7 and greater treatment success by week 12.
Patients treated with a topical JAK inhibitor experienced significant reductions in itch as early as day 7 and greater treatment success by week 12.
The award recognizes over two decades of contributions to research, innovation, and education in the field of aesthetic medicine.